For the year ending 2025-12-31, IMNN has $12,288,116 in assets. $5,226,240 in debts. $8,781,059 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 8,781,059 | |||
| Advances and deposits on clinical programs and other current assets | 1,942,685 | |||
| Total current assets | 10,723,744 | |||
| Property and equipment gross | 1,805,877 | |||
| Less accumulated depreciation and amortization | 1,275,941 | |||
| Property and equipment (at cost, less accumulated depreciation and amortization) | 529,936 | |||
| Operating lease right-of-use assets, net | 984,436 | |||
| Deposits and other assets | 50,000 | |||
| Total other assets | 1,034,436 | |||
| Total assets | 12,288,116 | |||
| Accounts payable trade | 1,392,829 | |||
| Other accrued liabilities | 2,824,646 | |||
| Operating lease liabilities - current portion | 406,354 | |||
| Total current liabilities | 4,623,829 | |||
| Operating lease liabilities - non-current portion | 602,411 | |||
| Total liabilities | 5,226,240 | |||
| Common stock - 0.01 par value (350,000,000 and 112,500,000 shares authorized at december 31, 2025 and 2024, respectively 3,419,652 and 966,714 shares issued at december 31, 2025 and 2024, respectively, and 3,419,650 and 966,712 shares outstanding at december 31, 2025 and 2024, respectively) | 34,197 | |||
| Additional paid-in capital | 428,410,939 | |||
| Accumulated deficit | -421,298,072 | |||
| Total stockholders equity before treasury stock | 7,147,064 | |||
| Treasury stock, at cost (2 shares at december 31, 2025 and 2024) | 85,188 | |||
| Total stockholders equity | 7,061,876 | |||
| Total liabilities and stockholders equity | 12,288,116 | |||
Imunon, Inc. (IMNN)
Imunon, Inc. (IMNN)